Moffitt Cancer Center Logo
 

Treatment

Where You Are:

 

Your Treatment Team for Esophageal Cancer

The GI Tumor Program offers a full range of diagnostic and cutting-edge treatment services, including:

Diagnostics

  • Endoscopic ultrasound (EUS)
  • EUS-guided biopsy
  • Endoscopic dilation
  • Esophageal stenting
  • Endoscopic mucosal resections
  • Esophagogastroduodenoscopy (EGD) for screening of high-risk patients with Barrett’s esophagus
  • Ablative therapies for premalignant conditions
  • High-resolution computed tomography
  • Positron emission testing with CT fusion
  • Esophageal pathology consultation

Surgery (High-Volume Surgeons)

Outcomes after surgery have been consistently improved at high-volume centers with high-volume surgeons and well-trained ancillary staff. Our high-volume surgeons offer cutting-edge approaches to esophageal surgery, including:

  • Minimally invasive/laparoscopic esophageal resections
  • Colonic interpositions
  • Robotic-assisted esophageal resections
  • Laparoscopic feeding tube placement

Medical Oncology

Novel combination chemotherapy for the treatment of primary and metastatic esophageal cancer

Radiation Oncology

  • Stereotactic body radiotherapy (SRBT)
  • Intensity modulated radiotherapy (IMRT)
  • Esophageal brachytherapy

Clinical Trials

The GI Tumor Program supports landmark research in drug discovery, surgery, molecular therapy, immune therapy, endoscopy, risk assessment and detection. Breakthrough discoveries in the lab become early stage translational research studies and then patient clinical trials. Moffitt is known for its cutting-edge research in personalized medicine, which designs targeted treatments that improve patient outcomes, reduce side effects and prevent disease recurrence.

 
 
TOOLS:   Font Size small font resizer separator font resizer separator big font resizer